Keywords: تریپسینوژن ایمونوژنیک; CF; cystic fibrosis; CFTR; cystic fibrosis transmembrane conductance regulator; CRD; Centre of Research and Dissemination; DNA; deoxyribonucleic acid; HAS; Haute Autorité de Santé; HTA; health technology assessment; ICER; incremental cost effectiveness
مقالات ISI تریپسینوژن ایمونوژنیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تریپسینوژن ایمونوژنیک; inconclusive screening results; mixed methods; maternal experience; CF; Cystic fibrosis; CFTR; Cystic fibrosis transmembrane regulator; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; RR; Response rate;
Keywords: تریپسینوژن ایمونوژنیک; immunoreactive trypsinogen; intestinal current measurement; nasal potential difference; newborn screening; sweat chloride; CF; Cystic fibrosis; CFFPR; CF Foundation Patient Registry; CFSPID; CF screen positive, inconclusive diagnosis; CFTR; CF transmembra
Keywords: تریپسینوژن ایمونوژنیک; CF screen positive; inconclusive diagnosis; CFSPID; CFTR; CFTR-related metabolic syndrome; CRMS; ICD-10; ICM; immunoreactive trypsinogen; intestinal current measurement; IRT; nasal potential difference; newborn screening; sweat test; CDC; Centers for Dise
Keywords: تریپسینوژن ایمونوژنیک; newborn screening; CF-screen positive, inconclusive diagnosis; CFTR-related metabolic syndrome; immunoreactive trypsinogen; intestinal current measurement; nasal potential difference; pancreatitis associated protein; sweat test; CF; Cystic fibrosis; CFSPI
Keywords: تریپسینوژن ایمونوژنیک; CF screen positive, inconclusive diagnosis; CFTR-related metabolic syndrome; immunoreactive trypsinogen; intestinal current measurement; nasal potential difference; newborn screening; pancreatitis associated protein; sweat test; CF; Cystic fibrosis; CFFPR
Keywords: تریپسینوژن ایمونوژنیک; AUC; area under curve; CF; cystic fibrosis; CFNBS; cystic fibrosis newborn screening; CFSPID; CF screen-positive inconclusive diagnosis; CI; confidence interval; IRT; immunoreactive trypsinogen; MI; meconium ileus; PAP; pancreatitis-associated protein.; C
Keywords: تریپسینوژن ایمونوژنیک; neonatal screening; accuracy; carriers; cystic fibrosis-related metabolic syndrome; CF; Cystic fibrosis; CFFNPR; CF Foundation National Patient Registry; CRMS; CF-related metabolic syndrome; DBS; Dried blood spot; IRT; Immunoreactive trypsinogen; NBS; New
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; CFFPR; Cystic Fibrosis Foundation Patient Registry; CFSPID; Cystic Fibrosis Screen Positive, Inconclusive Diagnosis; CFTR; Cystic fibrosis transmembrane conductance regulator; CFTR-RD; Cystic fibrosis transmembrane conductance regulat
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; CHW; The Children's Hospital at Westmead; CRMS; CF transmembrane conductance regulator-related metabolic syndrome; IRT; Immunoreactive trypsinogen; NBS; Newborn screening;
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; CFTR; CF transmembrane conductance regulator; COR; Clinician of record; FTE; Full-time equivalent; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PCP; Primary care provider;
A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System
Keywords: تریپسینوژن ایمونوژنیک; cystic fibrosis; CFTR gene mutations; newborn screening; genotyping; SNaPshot; CFTR; Cystic fibrosis transmembrane conductance regulator; ddNTP; Dideoxynucleotide; IRT; Immunoreactive trypsinogen; PCR; Polymerase chain reaction (PCR; SUS; Sistema Ãnico d
Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis
Keywords: تریپسینوژن ایمونوژنیک; 660W; Illumina 660W-Quad BeadChip; CF; Cystic fibrosis; CFTR; Cystic fibrosis transmembrane conductance regulator; IRT; Immunoreactive trypsinogen; NBS; Newborn screening/screened; Omni5; Illumina Omni5-Quad BeadChip; QC; Quality control; SNP; Single nucl
Neonatal screening for cystic fibrosis: Comparing the performances of IRT/DNA and IRT/PAP
Keywords: تریپسینوژن ایمونوژنیک; CF-NBS; cystic fibrosis newborn screening; IRT; immunoreactive trypsinogen; PAP; pancreatitis-associated protein; Neonatal screening; Cystic fibrosis; PAP; IRT; CFTR; Non-inferiority;
Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations
Keywords: تریپسینوژن ایمونوژنیک; CF; cystic fibrosis; CFNBS; cystic fibrosis newborn screening; DBS; dried blot spot; FS; failsafe strategy; IRT; immunoreactive trypsinogen; NBS; newborn screening; MI; meconium ileus; PAP; pancreatitis associated protein; PS; pancreatic sufficient; PI; p
Newborn screening for cystic fibrosis in Switzerland - Consequences after analysis of a 4 months pilot study
Keywords: تریپسینوژن ایمونوژنیک; Newborn screening; Cystic fibrosis; Immunoreactive trypsinogen; Recall rate;
Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland
Keywords: تریپسینوژن ایمونوژنیک; New born screening; Cystic fibrosis; Immunoreactive trypsinogen;
Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening
Keywords: تریپسینوژن ایمونوژنیک; Cystic fibrosis transmembrane conductance regulator; Immunoreactive trypsinogen; Sensitivity
The Importance of Sweat Testing for Older Siblings of Patients with Cystic Fibrosis Identified by Newborn Screening
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; IRT; Immunoreactive trypsinogen; ENT; Ear nose and throat; CFTR; Cystic fibrosis transmembrane regulator; ST; Sweat testing;
Newborn Screening for Cystic Fibrosis: A Lesson in Public Health Disparities
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PAP; Pancreatic associate protein;
Implementation of the French Nationwide Cystic Fibrosis Newborn Screening Program
Keywords: تریپسینوژن ایمونوژنیک; AFPDHE; French Association for the Screening and Prevention of Infant Handicaps; CF; Cystic fibrosis; CRCM; Cystic Fibrosis Resource and Skills Center; IRT; Immunoreactive trypsinogen;
Dépistage néonatal de la mucoviscidose, mise en place, implication des laboratoires et résultats nationaux
Keywords: تریپسینوژن ایمونوژنیک; Mucoviscidose; dépistage néonatal; centres de soins; trypsine immuno-réactive; CFTR; mutation modérée; Cystic fibrosis; neonatal screening; cystic fibrosis centers; immunoreactive trypsinogen; CFTR; mild mutation;
Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; CFTR; Cystic Fibrosis Transmembrane Conductance Regulator; FN; False-negative; HAZ; Height for age Z score; IRT; Immunoreactive trypsinogen; MI; Meconium ileus; NBS; Newborn screening; PI; Pancreatic insufficient; PS; Pancreatic suffi
Combining Immunoreactive Trypsinogen and Pancreatitis-Associated Protein Assays, a Method of Newborn Screening for Cystic Fibrosis that Avoids DNA Analysis
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; ELISA; Enzyme-linked immunosorbent assay; IRT; Immunoreactive trypsinogen; PAP; Pancreatitis-associated protein;
Sweat Testing Infants Detected by Cystic Fibrosis Newborn Screening
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; DBS; Dried blood spot; IRT; Immunoreactive trypsinogen; MA; Massachusetts; NBS; Newborn screening; QNS; Quantity not sufficient; [Clâ]; Chloride concentration; [Na+]; Sodium concentration;
Understanding Newborn Screening System Issues With Emphasis on Cystic Fibrosis Screening
Keywords: تریپسینوژن ایمونوژنیک; AAP; American Academy of Pediatrics; ACHDGDNC; Advisory Committee on Heritable Diseases and Genetic Disorders in Newborns and Children; ACMG; American College of Medical Genetics; CF; cystic fibrosis; DNA; deoxyribonucleic acid; HHS; US Department of Heal
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PCP; Primary care provider; RCT; Randomized controlled trial;
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; CFTR; Cystic fibrosis transmembrane conductance regulator; [Clâ]; Chloride concentration; DBS; Dried blood spot; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; QNS; Quantity not sufficient;
Challenges in Implementing a Successful Newborn Cystic Fibrosis Screening Program
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PCP; Primary care provider;
Assessing the cost of cystic fibrosis diagnosis and treatment
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; CFF; Cystic Fibrosis Foundation; CFTR; Cystic fibrosis transmembrane conductance regulator gene; DNA; Deoxyribonucleic acid; FEV1; Forced expiratory volume in 1 second; IRT; Immunoreactive trypsinogen; MI; Meconium ileus; NBS; Newborn
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions
Keywords: تریپسینوژن ایمونوژنیک; CDC; Center for Disease Control and Prevention; CF; Cystic fibrosis; CFTR; Cystic fibrosis transmembrane conductance regulator; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PKU; Phenylketonuria;
Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes
Keywords: تریپسینوژن ایمونوژنیک; ACMG; American College of Medical Genetics; CF; Cystic fibrosis; CFTR; Cystic fibrosis transmembrane conductance regulator; FN; False-negative results; IRT; Immunoreactive trypsinogen; NBS; Newborn screening;
Evidence on Improved Outcomes with Early Diagnosis of Cystic Fibrosis Through Neonatal Screening: Enough is Enough!
Keywords: تریپسینوژن ایمونوژنیک; CF; Cystic fibrosis; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PA; Pseudomonas aeruginosa; PI; Pancreatic insufficiency; PS; Pancreatic sufficiency; RCT; Randomized controlled trial; WCXR; Wisconsin chest x-ray score;
Policy issues for expanding newborn screening programs: The cystic fibrosis newborn screening experience in the United States
Keywords: تریپسینوژن ایمونوژنیک; CDC; Centers for Disease Control; CF; Cystic fibrosis; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PKU; Phenylketonuria; PPV; Positive predictive value;